Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Systemic second-line therapy
| N | % | |
|---|---|---|
| Second-line CTX received | ||
| Yes | 33 | 64.7 |
| No (BSC) | 18 | 35.3 |
| Second-line monoclonal antibody (N = 33) | ||
| Anti-angiogenic (Bev/Afli/Ram) | 11 | 33.3 |
| EGFR (Panitumumab/Cetuximab) | 13 | 39.4 |
| None | 9 | 27.3 |
| Chemotherapy backbone | ||
| Oxaliplatin-based (FOLFOX/CAPOX) | 6 | 18.2 |
| Irinotecan-based (FOLFIRI, Irinotecan) | 10 | 30.3 |
| FOLFOXIRI | 3 | 9.1 |
| Fluoropyrimidin mono | 3 | 9.1 |
| Encorafenib | 10 | 30.3 |
| Pembrolizumab | 1 | 3.0 |
